Spectrum Pharmaceuticals, Inc. to Present at the Biotechnology Industry Organization (BIO) CEO Investor Conference in New York City on Tuesday, February 9th

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, announced today that Rajesh C. Shrotriya MD, Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals, will provide an overview of the Company’s business strategy at the 2010 BIO CEO Investor Conference on Tuesday, February 9, 2010, at 11:30am Eastern Time. The conference is being held at the Waldorf Astoria Hotel in New York City. The Spectrum Pharmaceutical presentation will be given in the Basildon room.
MORE ON THIS TOPIC